Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Noninvasive prenatal HPA-1 typing in HPA-1a negative pregnancies selected in the Polish PREVFNAIT screening program.

Orzińska A, Guz K, Uhrynowska M, Dębska M, Mikula M, Ostrowski J, Ahlen MT, Husebekk A, Brojer E.

Transfusion. 2018 Nov;58(11):2705-2711. doi: 10.1111/trf.14963. Epub 2018 Sep 27.

PMID:
30260485
2.

Identification and follow-up of pregnant women with platelet-type human platelet antigen (HPA)-1bb alloimmunized with fetal HPA-1a.

Dębska M, Uhrynowska M, Guz K, Kopeć I, Lachert E, Orzińska A, Kretowicz P, Antoniewicz-Papis J, Dębski R, Łętowska M, Husebekk A, Brojer E.

Arch Med Sci. 2018 Aug;14(5):1041-1047. doi: 10.5114/aoms.2016.63600. Epub 2016 Nov 15.

3.

Screening for fetal and neonatal alloimmune thrombocytopenia - lessons learned from a Norwegian screening program.

Kjaer M, Kjeldsen-Kragh J, Fiskum C, Leinan I, Skogen B, Husebekk A.

Acta Obstet Gynecol Scand. 2018 Jun;97(6):766-767. doi: 10.1111/aogs.13320. Epub 2018 Mar 5. No abstract available.

PMID:
29412452
4.

Fetal exposure to maternal human platelet antigen-1a does not induce tolerance. An analytical observational study.

Kjær M, Tiller H, Heide G, Kjeldsen-Kragh J, Skogen B, Husebekk A.

PLoS One. 2017 Aug 24;12(8):e0182957. doi: 10.1371/journal.pone.0182957. eCollection 2017.

5.

Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia-Antibody specificity analysis using epitope data.

Dahl J, Refsum E, Ahlen MT, Egeland T, Jensen T, Viken MK, Stuge TB, Acharya G, Husebekk A, Skogen B, Tiller H.

J Reprod Immunol. 2017 Aug;122:1-9. doi: 10.1016/j.jri.2017.06.003. Epub 2017 Jun 27.

PMID:
28686909
6.

Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.

Tiller H, Husebekk A, Ahlen MT, Stuge TB, Skogen B.

Int J Womens Health. 2017 Apr 19;9:223-234. doi: 10.2147/IJWH.S90753. eCollection 2017. Review.

7.

Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model.

Eksteen M, Heide G, Tiller H, Zhou Y, Nedberg NH, Martinez-Zubiaurre I, Husebekk A, Skogen BR, Stuge TB, Kjær M.

Reprod Biol Endocrinol. 2017 Apr 21;15(1):28. doi: 10.1186/s12958-017-0245-6.

8.

Recent advances in understanding the clinical relevance of antiplatelet alloantibodies.

Guz K, Uhrynowska M, Kopeć I, Dębska M, Husebekk A, Brojer E.

Pol Arch Intern Med. 2017 Mar 31;127(3):190-194. doi: 10.20452/pamw.3932. Epub 2017 Feb 3. Review.

9.

T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.

Ahlen MT, Husebekk A, Killie IL, Skogen B, Stuge TB.

JCI Insight. 2016 Sep 8;1(14):e86558. doi: 10.1172/jci.insight.86558.

10.

Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.

Weng YJ, Husebekk A, Skogen B, Kjaer M, Lin LT, Burnouf T.

PLoS One. 2016 Sep 14;11(9):e0162973. doi: 10.1371/journal.pone.0162973. eCollection 2016.

11.

Raiders of the lost mark - endothelial cells and their role in transplantation for hematologic malignancies.

Blix ES, Husebekk A.

Leuk Lymphoma. 2016 Dec;57(12):2752-2762. Epub 2016 Jul 10. Review.

PMID:
27396981
12.

Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.

Brojer E, Husebekk A, Dębska M, Uhrynowska M, Guz K, Orzińska A, Dębski R, Maślanka K.

Arch Immunol Ther Exp (Warsz). 2016 Aug;64(4):279-90. doi: 10.1007/s00005-015-0371-9. Epub 2015 Nov 12. Review.

13.

Maternal anti-HLA class I antibodies are associated with reduced birth weight in thrombocytopenic neonates.

Dahl J, Husebekk A, Acharya G, Flo K, Stuge TB, Skogen B, Straume B, Tiller H.

J Reprod Immunol. 2016 Feb;113:27-34. doi: 10.1016/j.jri.2015.10.003. Epub 2015 Oct 29.

PMID:
26547815
14.

A longitudinal study of maternal endothelial function, inflammatory response and uterine artery blood flow during the second half of pregnancy.

Flo K, Blix ES, Husebekk A, Thommessen A, Uhre AT, Wilsgaard T, Vårtun Å, Acharya G.

Acta Obstet Gynecol Scand. 2016 Feb;95(2):225-32. doi: 10.1111/aogs.12802. Epub 2015 Nov 17.

PMID:
26462064
15.

A multicenter validation of recombinant β3 integrin-coupled beads to detect human platelet antigen-1 alloantibodies in 498 cases of fetomaternal alloimmune thrombocytopenia.

Chong W, Turro E, Metcalfe P, Yusuf R, Mérieux Y, Rigal D, Porcelijn L, Huiskes E, Lucas G, Bendukidze N, Green A, Fontão-Wendel R, Husebekk A, Dixey J, Guest A, Mushens R, Ouwehand WH, Navarrete CV.

Transfusion. 2015 Nov;55(11):2742-51. doi: 10.1111/trf.13222. Epub 2015 Jul 14.

PMID:
26173471
16.

Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy.

Eksteen M, Tiller H, Averina M, Heide G, Kjaer M, Ghevaert C, Michaelsen TE, Ihle Ø, Husebekk A, Skogen B, Stuge TB.

J Immunol. 2015 Jun 15;194(12):5751-60. doi: 10.4049/jimmunol.1401599. Epub 2015 May 13.

17.

True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study.

Tiller H, Husebekk A, Skogen B, Kjeldsen-Kragh J, Kjaer M.

BJOG. 2016 Apr;123(5):738-44. doi: 10.1111/1471-0528.13343. Epub 2015 Mar 9.

18.

Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma.

Blix ES, Kildal AB, Bertelsen E, Waage A, Myklebust JH, Kolstad A, Husebekk A.

Biol Blood Marrow Transplant. 2015 May;21(5):840-7. doi: 10.1016/j.bbmt.2014.12.027. Epub 2015 Feb 14.

19.

Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.

Viet L, Husebekk A, Husum H, Skjerve E.

Transfus Med. 2013 Dec;23(6):423-31. doi: 10.1111/tme.12053. Epub 2013 Jun 21.

PMID:
23786316
20.

A newborn with petechiae.

Eriksen BH, Husebekk A, Fugelseth D, Salberg KR, Lindemann R.

Tidsskr Nor Laegeforen. 2013 Apr 9;133(7):761-4. doi: 10.4045/tidsskr.12.1009. English, Norwegian. No abstract available.

21.

Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry.

Tiller H, Kamphuis MM, Flodmark O, Papadogiannakis N, David AL, Sainio S, Koskinen S, Javela K, Wikman AT, Kekomaki R, Kanhai HH, Oepkes D, Husebekk A, Westgren M.

BMJ Open. 2013 Mar 22;3(3). pii: e002490. doi: 10.1136/bmjopen-2012-002490.

22.

The DR7-DQ2 haplotype in a native Norwegian population.

Heide G, Stuge TB, Skogen B, Husebekk A, Ahlen MT.

Scand J Immunol. 2013 May;77(5):429-30. doi: 10.1111/sji.12031. No abstract available.

23.

Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.

Blix ES, Irish JM, Husebekk A, Delabie J, Forfang L, Tierens AM, Myklebust JH, Kolstad A.

BMC Cancer. 2012 Oct 16;12:478. doi: 10.1186/1471-2407-12-478.

24.

Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.

Blix ES, Irish JM, Husebekk A, Delabie J, Tierens AM, Myklebust JH, Kolstad A.

Br J Haematol. 2012 Dec;159(5):604-8. doi: 10.1111/bjh.12073. Epub 2012 Oct 9. No abstract available.

25.

Prevalence of hepatitis B & hepatitis C virus infections in potential blood donors in rural Vietnam.

Viet L, Lan NT, Ty PX, Björkvoll B, Hoel H, Gutteberg T, Husebekk A, Larsen S, Skjerve E, Husum H.

Indian J Med Res. 2012 Jul;136(1):74-81.

26.

The proteoglycan repertoire of lymphoid cells.

Fadnes B, Husebekk A, Svineng G, Rekdal Ø, Yanagishita M, Kolset SO, Uhlin-Hansen L.

Glycoconj J. 2012 Oct;29(7):513-23. doi: 10.1007/s10719-012-9427-9. Epub 2012 Jul 10.

27.

Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.

Husebekk A, El Ekiaby M, Gorgy G, Killie MK, Uhlin-Hansen C, Salma W, Navarrete C, El Afandi M, Skogen B, Ahlen MT.

Transfus Apher Sci. 2012 Dec;47(3):277-82. doi: 10.1016/j.transci.2012.04.001. Epub 2012 May 27.

PMID:
22640833
28.

Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.

Tiller H, Killie MK, Chen P, Eksteen M, Husebekk A, Skogen B, Kjeldsen-Kragh J, Ni H.

Transfusion. 2012 Jul;52(7):1446-57. doi: 10.1111/j.1537-2995.2011.03480.x. Epub 2012 Jan 17.

PMID:
22251227
29.

IFPA Meeting 2011 workshop report III: Placental immunology; epigenetic and microRNA-dependent gene regulation; comparative placentation; trophoblast differentiation; stem cells.

Ackerman WE 4th, Bulmer JN, Carter AM, Chaillet JR, Chamley L, Chen CP, Chuong EB, Coleman SJ, Collet GP, Croy BA, de Mestre AM, Dickinson H, Ducray J, Enders AC, Fogarty NM, Gauster M, Golos T, Haider S, Heazell AE, Holland OJ, Huppertz B, Husebekk A, John RM, Johnsen GM, Jones CJ, Kalionis B, König J, Lorenzon AR, Moffett A, Moreira de Mello JC, Nuzzo AM, Parham P, Parolini O, Petroff MG, Pidoux G, Ramírez-Pinilla MP, Robinson WP, Rolfo A, Sadovsky Y, Soma H, Southcombe JH, Tilburgs T, Lash GE.

Placenta. 2012 Feb;33 Suppl:S15-22. doi: 10.1016/j.placenta.2011.11.022. Epub 2011 Dec 10.

30.

[Nobel Prize in medicine 2011].

Husebekk A.

Tidsskr Nor Laegeforen. 2011 Nov 29;131(23):2332. doi: 10.4045/tidsskr.11.1313. Norwegian. No abstract available.

31.

The development of severe neonatal alloimmune thrombocytopenia due to anti-HPA-1a antibodies is correlated to maternal ABO genotypes.

Ahlen MT, Husebekk A, Killie MK, Kjeldsen-Kragh J, Olsson ML, Skogen B.

Clin Dev Immunol. 2012;2012:156867. doi: 10.1155/2012/156867. Epub 2011 Nov 2.

32.

Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.

Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Øian P.

Acta Obstet Gynecol Scand. 2012 Jan;91(1):79-86. doi: 10.1111/j.1600-0412.2011.01269.x. Epub 2011 Oct 13.

PMID:
21895612
33.

The pathophysiology of FNAIT cannot be deduced from highly selected retrospective data.

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Blood. 2011 Sep 1;118(9):2638-9. doi: 10.1182/blood-2011-06-360404. No abstract available.

PMID:
21885616
34.

The cellular immunobiology associated with fetal and neonatal alloimmune thrombocytopenia.

Stuge TB, Skogen B, Ahlen MT, Husebekk A, Urbaniak SJ, Bessos H.

Transfus Apher Sci. 2011 Aug;45(1):53-9. doi: 10.1016/j.transci.2011.06.003. Epub 2011 Jun 25. Review.

PMID:
21708486
35.

Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention.

Skogen B, Killie MK, Kjeldsen-Kragh J, Ahlen MT, Tiller H, Stuge TB, Husebekk A.

Expert Rev Hematol. 2010 Oct;3(5):559-66. doi: 10.1586/ehm.10.49. Review.

PMID:
21083473
36.

Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam.

Bjoerkvoll B, Viet L, Ol HS, Lan NT, Sothy S, Hoel H, Gutteberg T, Husebekk A, Larsen S, Husum H.

Southeast Asian J Trop Med Public Health. 2010 Sep;41(5):1127-35.

PMID:
21073033
37.

Increased risk of transmission of hepatitis C in open heart surgery compared with vascular and pulmonary surgery.

Olsen K, Dahl PE, Paulssen EJ, Husebekk A, Widell A, Busund R.

Ann Thorac Surg. 2010 Nov;90(5):1425-31. doi: 10.1016/j.athoracsur.2010.06.053.

PMID:
20971233
38.

[Severe immune reaction without microbes].

Husebekk A.

Tidsskr Nor Laegeforen. 2010 Sep 23;130(18):1832-3. doi: 10.4045/tidsskr.10.0780. Norwegian. No abstract available.

39.

Quantitative MAIPA: Comparison of different MAIPA protocols.

Killie MK, Salma W, Bertelsen E, Skogen B, Husebekk A.

Transfus Apher Sci. 2010 Oct;43(2):149-54. doi: 10.1016/j.transci.2010.07.001. Epub 2010 Aug 2.

PMID:
20675194
40.

Neonatal alloimmune thrombocytopenia is not what it was: a lesson learned from a large prospective screening and intervention program.

Skogen B, Husebekk A, Killie MK, Kjeldsen-Kragh J.

Scand J Immunol. 2009 Dec;70(6):531-4. doi: 10.1111/j.1365-3083.2009.02339.x. Review.

41.

Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.

Ol HS, Bjoerkvoll B, Sothy S, Van Heng Y, Hoel H, Husebekk A, Gutteberg T, Larsen S, Husum H.

Southeast Asian J Trop Med Public Health. 2009 Sep;40(5):963-71.

PMID:
19842380
42.

Is it time to implement HPA-1 screening in pregnancy?

Husebekk A, Killie MK, Kjeldsen-Kragh J, Skogen B.

Curr Opin Hematol. 2009 Nov;16(6):497-502. doi: 10.1097/MOH.0b013e3283317be9. Review.

PMID:
19730261
43.

Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.

Olsen T, Cui G, Goll R, Husebekk A, Florholmen J.

Scand J Gastroenterol. 2009;44(6):727-35. doi: 10.1080/00365520902803507.

PMID:
19294580
44.

Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme.

Tiller H, Killie MK, Skogen B, Øian P, Husebekk A.

BJOG. 2009 Mar;116(4):594-8. doi: 10.1111/j.1471-0528.2008.02068.x.

45.

In HPA 1a-immunized women the decrease in anti-HPA 1a antibody level during pregnancy is not associated with anti-idiotypic antibodies.

Kjeldsen-Kragh J, Kim M, Killie MK, Husebekk A, Freedman J, Semple JW.

Haematologica. 2009 Mar;94(3):441-3. doi: 10.3324/haematol.13827. Epub 2009 Jan 30. No abstract available.

46.

T-cell responses associated with neonatal alloimmune thrombocytopenia: isolation of HPA-1a-specific, HLA-DRB3*0101-restricted CD4+ T cells.

Ahlen MT, Husebekk A, Killie MK, Skogen B, Stuge TB.

Blood. 2009 Apr 16;113(16):3838-44. doi: 10.1182/blood-2008-09-178475. Epub 2009 Jan 9.

PMID:
19136661
47.

Direct comparison between two quantitative assays in the measurement of maternal anti-HPA-1a antibody in neonatal alloimmune thrombocytopenia (NAIT).

Bessos H, Killie MK, Matviyenko M, Husebekk A, Urbaniak SJ.

Transfus Apher Sci. 2008 Dec;39(3):221-7. doi: 10.1016/j.transci.2008.09.006. Epub 2008 Oct 21.

PMID:
18945639
48.

What's happening--probing of HPA-1a antigen-antibody interaction by surface plasmon resonance technology.

Bessos H, Matviyenko M, Brown P, Husebekk A, Killie MK, Seghatchian J, Santoso S, Urbaniak SJ.

Transfus Apher Sci. 2008 Oct;39(2):179-82. doi: 10.1016/j.transci.2008.06.005.

PMID:
18710823
49.

Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme?

Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B.

Transfus Apher Sci. 2008 Jun;38(3):183-8. doi: 10.1016/j.transci.2008.04.010. Epub 2008 May 21. Review.

PMID:
18499524
50.

A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn.

Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B.

Haematologica. 2008 Jun;93(6):870-7. doi: 10.3324/haematol.12515. Epub 2008 Apr 28.

Supplemental Content

Loading ...
Support Center